SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-19-005213
Filing Date
2019-09-13
Accepted
2019-09-13 08:34:25
Documents
7
Period of Report
2019-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2239675z8-k.htm 8-K 37779
2 EX-2.1 a2239675zex-2_1.htm EX-2.1 523067
3 EX-10.1 a2239675zex-10_1.htm EX-10.1 132432
4 EX-10.2 a2239675zex-10_2.htm EX-10.2 110670
5 EX-99.1 a2239675zex-99_1.htm EX-99.1 173305
6 EX-99.2 a2239675zex-99_2.htm EX-99.2 124384
7 G423687.JPG g423687.jpg GRAPHIC 15349
  Complete submission text file 0001047469-19-005213.txt   1124413
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31564 | Film No.: 191091583
SIC: 2834 Pharmaceutical Preparations